Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Pimecrolimus
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Pimecrolimus and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Theoretically, coadministration with CYP450 3A inhibitors may increase the plasma concentrations of pimecrolimus, which has been shown in vitro to undergo metabolism by this subfamily of hepatic microsomal enzymes. Although clinically significant drug interactions are not expected due to minimal systemic absorption of topically administered pimecrolimus, the possibility cannot be ruled out. The manufacturer recommends caution in patients with widespread and/or erythrodermic disease.
- "Product Information. Elidel (pimecrolimus topical)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir
Generic Name: pimecrolimus topical
Brand name: Elidel
Synonyms: Pimecrolimus topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pimecrolimus Cream
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pimecrolimus topical
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pimozide
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pimtrea
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pin-X
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Pin-X (Pyrantel Pamoate Chewable Tablets)
- Pimecrolimus-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Pimecrolimus-Omeclamox-Pak
- Pimecrolimus-Omega-3 Fatty Acid Capsules
- Pimecrolimus-Omega-3 Fatty Acids
- Pimecrolimus-Omega-3 polyunsaturated fatty acids
- Pimecrolimus-Omega-3-acid ethyl esters